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Pseudomonas aeruginosa is an ubiquitous gram-negative opportunistic human
pathogen which is not considered part of the human commensal gut microbiota.
However, depletion of the intestinal microbiota (Dysbiosis) following antibiotic treatment
facilitates the colonization of the intestinal tract by Multidrug-Resistant P. aeruginosa.
One possible strategy is based on the use of functional foods with prebiotic activity. The
bifidogenic effect of the prebiotic inulin and its hydrolyzed form (fructooligosaccharide:
FOS) is well established since they promote the growth of specific beneficial (probiotic)
gut bacteria such as bifidobacteria. Previous studies of the opportunistic nosocomial
pathogen Pseudomonas aeruginosa PAO1 have shown that inulin and to a greater
extent FOS reduce growth and biofilm formation, which was found to be due to a
decrease in motility and exotoxin secretion. However, the transcriptional basis for these
phenotypic alterations remains unclear. To address this question we conducted RNA-
sequence analysis. Changes in the transcript level induced by inulin and FOS were
similar, but a set of transcript levels were increased in response to inulin and reduced
in the presence of FOS. In the presence of inulin or FOS, 260 and 217 transcript
levels, respectively, were altered compared to the control to which no polysaccharide
was added. Importantly, changes in transcript levels of 57 and 83 genes were found
to be specific for either inulin or FOS, respectively, indicating that both compounds
trigger different changes. Gene pathway analyses of differentially expressed genes
(DEG) revealed a specific FOS-mediated reduction in transcript levels of genes that
participate in several canonical pathways involved in metabolism and growth, motility,
biofilm formation, β-lactamase resistance, and in the modulation of type III and VI
secretion systems; results that have been partially verified by real time quantitative
PCR measurements. Moreover, we have identified a genomic island formed by a
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cluster of 15 genes, encoding uncharacterized proteins, which were repressed in the
presence of FOS. The analysis of isogenic mutants has shown that genes of this
genomic island encode proteins involved in growth, biofilm formation and motility. These
results indicate that FOS selectively modulates bacterial pathogenicity by interfering with
different signaling pathways.
Keywords: RNA sequencing, rt-qPCR, adhesion, developmental process, molecular transducer, pathogenicity
INTRODUCTION
The human pathogen Pseudomonas aeruginosa causes a wide
array of life-threatening acute and chronic infections, particularly
in immunocompromised, cancer, burn wound, and cystic fibrosis
patients (Juhas, 2015). This bacterium is moreover one of the
leading causes of nosocomial infections affecting hospitalized
patients (Buhl et al., 2015) and mortality associated with hospital-
acquired P. aeruginosa infectious like ventilator-associated
pneumonia or bacteremia is above 35% (Lynch et al., 2017).
Moreover, under continuous antibiotic treatment the
intestinal microbiota integrity is compromised and bears
depletion of the intestinal microbiota (Dysbiosis), hence,
physiological colonization resistance subsequently facilitates the
establishment of the Pseudomonas aeruginosa in the intestinal
ecosystem which might be considered an important internal
source for P. aeruginosa infection (Ohara and Itoh, 2003; Von
Klitzing et al., 2017). It is important to note that pathological
alterations of the intestinal microbiota (dysbiosis) is related with
continuous antibiotic treatment, obesity, diabetes and fatty liver,
and of course alterations of the intestinal barrier function (IBF)
as in inflammatory bowel disease and metabolic syndrome (Cano
et al., 2013; Miura and Ohnishi, 2014).
The severity and permanence of these infections are related
to the ability of P. aeruginosa to resist the effect of antibiotics
through the formation of biofilms (Mah et al., 2003; Hoiby et al.,
2010; Taylor et al., 2014). Important research efforts have been
made to study the molecular mechanisms related to the formation
maturation and subsequent dispersion of the biofilm (Stoodley
et al., 2002; Flemming et al., 2007). A number of surface proteins
and appendages, including flagella and type IV pili, were found
to be associated with biofilm formation (Klausen et al., 2003;
Anyan et al., 2014). Furthermore, this species is characterized
by its ability to synthesize the virulent factors exotoxin A and
pyocyanin (Ortiz-Castro et al., 2014) that block protein synthesis
consequently leading to cell death (Gaines et al., 2007).
Treatment of P. aeruginosa infections can be particularly
challenging because this bacterium is intrinsically resistant to
multiple antibiotics and can easily acquire new resistances
(Breidenstein et al., 2011). In fact, over the past three decades,
antibiotic resistance among P. aeruginosa has escalated globally,
via the global dissemination of several multidrug-resistant
epidemic clones (Miyoshi-Akiyama et al., 2017). Pseudomonas
aeruginosa infections thus represent a severe threat to human
health worldwide and the World Health Organization has
declared this bacterium the second priority pathogen for research
and development of new strategies to fight it (WHO, 2017).
Besides conventional treatments, one possible strategy is
based on the use of functional foods with prebiotic activity
which are non-digestible foods (mostly oligosaccharides) that
selectively stimulate the growth of a limited number of host-
friendly colonic bacteria (Froebel et al., 2019). Thus, from a
chemical standpoint, resistance to human digestive enzymes
and low absorption are key for these compounds to reach
the distal parts of the gut, where they can be fermented
by the microbiota, which in turn is selectively modified
in the process. These additional actions of prebiotics tend
to enhance the capacity of the mucosa to contain luminal
microorganisms and their components, i.e., intestinal barrier
function (IBF). Normally, passage of microorganisms and/or
their components such as Lipopolysaccharides (LPS) to the
mucosa and from there to the bloodstream (translocation)
is minimal, and the immune system develops tolerance
to the microbiota, without inflammation. Conversely, when
IBF is compromised translocation ensues, depending on the
nature of the dysfunction and the physiological/pathological
context. Therefore, inflammation of the intestine is considered
to stem from augmented translocation, which engages the
adaptive immune system, ultimately resulting in uncontrolled
inflammation. Thus, reinforcing IBF may be protective and is
viewed as therapeutic in this context (Natividad and Verdu, 2012;
Duseja and Chawla, 2014).
A significant number of natural compounds have been
found to inhibit bacterial growth, although their mechanisms
of action frequently remain unclear (Amer et al., 2010).
Fructooligosaccharides (FOS) are short-chain oligosaccharides
that are generated by hydrolysis of the polysaccharide inulin,
which is composed of two to 60 fructose monomers. Inulin is
found in different nutrients such as wheat, onion, garlic and
banana (Lattimer and Haub, 2010) and is the most common
used fiber in prebiotics that, when used in combination with
other probiotics, is able to promote the growth of specific
beneficial gut bacteria such as bifidobacteria (Gibson et al., 1995;
Bosscher et al., 2006).
TABLE 1 | Statistics of RNA-seq data.




MM9-citrate 7472385 6322981 1149404 84.6%
Inulin 5368865 4575351 793514 85.2%
FOS 6598306 5580131 1018175 84.6%
Shown are means from two replicates.
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FIGURE 1 | Heat-map (A) analysis and hierarchical cluster (B) of the genes that are differentially induced and repressed in the presence of FOS or inulin as
compared to the untreated control (M9 minimal medium). Blue: genes with increased expression; red: genes with reduced expression.
A number of studies illustrate that FOS and inulin exert
a number of different effects on humans and animals. For
example, most oraly delivered plant substrate supplements that
prevent gastrointestinal infections such as prebiotinTM and
symbioramTM contain inulin and FOS, indicating that these
compounds are also able to reduce bacterial infection. Moreover,
oligosaccharids and in particular inulin and FOS were found
to have beneficial effects on intestinal immunity and intestinal
barrier function (IBF) (Capitán-Cañadas et al., 2013, 2016).
Another study has shown that oligosaccharides from goats milk
as well as galactooligosaccharides, modulate cytokine production
by intestinal epithelial cells and monocytes via a mechanism
involving Toll-like receptor 4 (TLR4) (Capitán-Cañadas et al.,
2013). TLRs are located on the cell membrane and in endosomes,
where they recognize components of cell membranes (TLR2/6,
TLR2/TLR4), nucleic acids (TLR3, 7, 8, and 9) and flagellin
(TLR5). TLR4 is one of the non-pathogen recognition receptors
(PRRs), which are key elements in the communication between
the host and the microbiota (Sánchez de Medina et al., 2013).
However, further clinical oral applications will require studies
on the potential effects of these natural substrates on the human
body, which corresponds to the research need addressed in
this article.
In addition to the bacterial growth promoting role of inulin
and FOS, we reported that FOS inhibited bacterial growth and
biofilm formation of P. aeruginosa PAO1 (Ortega-González et al.,
2014). Additionally, both compounds caused opposing effects on
bacterial motility. While FOS inhibited motility, an increased
motility was observed in the presence of inulin. Moreover, in
co-cultures with eukaryotic cells (macrophages) FOS, and to a
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lesser extent inulin, reduced the secretion of the inflammatory
cytokines IL-6, IL-10, and TNF-α. We were also able to show
that the reduction in cytokine secretion is due to a FOS-
mediated modulation of the NF-κβ signal transduction pathway
(Ortega-González et al., 2014). To gain insight into the detailed
molecular processes triggered by FOS and inulin, we report here
results from RNA-seq studies.
MATERIALS AND METHODS
Materials
Inulin and FOS were purchased from BENEO-Orafti (Tienen
Belgium). Stock solutions at 200 g/L in modified M9 minimal
medium were sterilized using 0.22 µm cut-off filters and aliquots
were stored at−20◦C.
Culture and Growth Conditions
Pseudomonas aeruginosa PAO1 was grown overnight at 37◦C in
minimum M9 medium. The resulting cultures were then used to
inoculate 50 ml of minimum M9 medium supplemented by 5 mM
of citrate (MM9) (in 250 ml Erlenmeyer flasks) to an initial OD600
of 0.01 and incubated with shaking at 200 rpm at 37◦C. When
cultures reached OD600 = 0.05, FOS or inulin were added to a
final concentration of 20 mg/ml and cultures were harvested for
analysis 1 h later.
RNA Extraction, Library Preparation and
RNA Sequencing
Total RNA was extracted with the TRI reagent (Ambion) using
the manufacturer’s instructions. The RNase inhibitor RiboLock
(Fermentas) was added to the samples and DNA was removed
by treatment with DNase I (Fermentas). The integrity of the
RNA samples was assessed with an Agilent 2100 Bioanalyzer
(Agilent Technologies). Subsequently, the 23S, 16S, and 5S
rRNAs were removed by subtractive hybridization using the
MICROBExpress kit (Ambion) following the protocol reported
by Gómez-Lozano et al. (2014). Removal of the rRNA was
confirmed by an analysis with an Agilent 2100 Bioanalyzer
(Agilent Technologies). Sequencing libraries were prepared using
the TruSeq Stranded mRNA Sample Preparation kit (Illumina).
After each step, the samples were validated using an Agilent
2100 Bioanalyzer (Agilent Technologies) and the final RNA
concentration was measured using a Qubit 2.0 Fluorometer
(Invitrogen). The libraries were sequenced using the Illumina
HiSeq2000 platform with a paired-end protocol and read lengths
of 100 nucleotides.
RNA-seq Analysis
The quality of sequenced reads was assessed using FastQC
software, version 0.11.5 (Andrews and Fast, 2010). Single-end
reads were aligned to the reference genome of P. aeruginosa
PAO1 (GenBank accession number: AE004091.2) using
SAMtools v 0.1.19 (Li et al., 2009). BAM files from SAM
tools were used as input for the feature counts function (Liao
et al., 2014) from the Rsubread package (Liao et al., 2013) of
FIGURE 2 | Venn diagrams comparing gene transcript levels in the presence
of inulin and FOS. (A) Genes down regulated by inulin and FOS. (B) Genes up
regulated by inulin and FOS.
Bioconductor version 3.5 to generate a matrix of annotated genes
with their corresponding raw counts. An average of 84.5% reads
were successfully mapped to the reference genome. The count
data were then analyzed to look for differential gene expression
levels and statistical significance using DEseq2 (Love et al., 2014;
Kimberly and Stephen, 2015).
The threshold to define differences in transcript levels was a
statistical Log2 fold change. Genes were considered significantly
differentially expressed when p-values were below 0.05.
RNA-Sequencing Data Registration
Number
The sequence reads have been deposited in the GEO database
under accession N◦: GSE124468. The following secure token
has been created to allow for the review of record GSE124468:
glshocwuzvkprop.
Analysis of Gene Expression by
Quantitative Real Time PCR
Quantitative real time-PCR experiments were performed to
validate RNA-seq results. Total RNA was obtained by the
TRI reagent R© /BCP method (Ambion). One µg of RNA
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TABLE 2 | Transcript levels that were reduced in the presence of both, inulin and FOS.
Gene Id Gene Protein Function Inulin FOS
log2 fold change p-value (10−6) log2 fold change p-value (10−6)
PA0090 clpV1 Type VI secretion ATPase −0.9 0.000 −0.8 0.000
PA0296 spuI Glutamylpolyamine synthetase −0.6 0.008 −0.6 0.007
PA0795 prpC Citrate synthase 2 −1.1 0.001 −0.9 0.002
PA1069 nd Hypothetical protein −0.7 0.000 −0.5 0.003
PA1171 sltB2 Soluble lytic transglycolase −0.7 0.010 −0.6 0.008
PA1183 dctA C4-dicarboxylate transport protein −1.5 0.000 −1.2 0.000
PA1342 aatj Probable binding protein component of ABC transporter −1.0 0.000 −1.1 0.000
PA1585 sucA 2-oxoglutarate dehydrogenase −0.5 0.008 −0.6 0.001
PA1588 sucC Succinyl-CoA synthetase −0.7 0.000 −0.6 0.002
PA1592 nd Hypothetical protein −0.9 0.000 −0.8 0.001
PA1787 acnB Aconitate hydratase B −0.5 0.003 −0.5 0.003
PA2007 maiA Maleylacetatoacetate isomerase −1.1 0.000 −0.7 0.003
PA2008 fahA Fumarylacetoacetase −1.1 0.000 −1.1 0.000
PA2040 pauA4 Glutamylpolyamine synthetase −0.9 0.000 −0.7 0.002
PA2247 bkdA1 2-oxoisovalerate dehydrogenase −0.9 0.001 −0.7 0.004
PA4055 ribC Riboflavin synthase −0.7 0.009 −0.7 0.005
PA4240 rpsK 30S ribosomal protein S11 −0.7 0.003 −1.0 0.000
PA4366 sodB Superoxide dismutase −0.7 0.000 −0.7 0.000
PA4370 icmP Insulin-cleaving metalloproteinase outer membrane protein −0.8 0.002 −0.9 0.000
PA4578 nd Hypothetical protein −0.9 0.000 −0.8 0.000
PA4824 nd Hypothetical protein −0.9 0.000 −0.8 0.000
PA4825 mgtA Mg(2 +) transport ATPase P-type 2 −0.9 0.000 −0.8 0.000
The above table shows the list of the significant down regulated genes and control with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.
was retrotranscribed following the protocol provided in the
manufacturer protocol (iScript BioRad, Alcobendas, Spain)
and DNA sequences were amplified with a MX3005P real
time PCR instrument (Stratagene) using the primers listed in
Supplementary Table S3. The genes of interest were amplified by
PCR using the Go Taq@qPCR Master Mix (Promega, Madison,
WI, United States) as well as 1 µl of the cDNA template and
the primers listed in Supplementary Table S3. Forty PCR cycles
were conducted using an annealing temperature of 61◦C. The
cycle threshold values were normalized to that of the reference
transcript, 16S RNA, and data were normalized to the control.
Generation of Mutants in Genes of the
Genomic Island PA0643, PA0644, and
PA0646
To generate the PA0643:Gm, PA0644:Gm, and PA0646:Gm
mutants 656, 241, and 636 pb DNA fragments, respectively,
covering the central part of the genes were amplified by PCR
from P. aeruginosa PA01 genomic DNA. The resulting products
were cloned into plasmid pMBL to yield plasmids pMBL:PA0643,
pMBL:PA0644, and pMBL:PA0646. Subsequently, the resulting
plasmids were digested with BamHI, which liberated the PA0643,
PA0644, and PA0646 fragment. The plasmid pCHESI was also
digested with BamHI, to liberate the gentamicin resistance gene
(Gm) in order to ligate it with the three DNA fragments. The
resulting chimeric DNA was cloned into pMBL digested with
BamHI, to yield pMBL:PA0643Gm, pMBL:PA0644Gm and
pMBL:PA0646Gm. The resulting plasmids were electroporated
into P. aeruginosa PA01 for homologous double recombination.
Mutant strains were selected on Gm plates and the correctness of
the mutation was verified by Southern blotting (Sambrook et al.,
1989; Molina-Fuentes et al., 2015).
Semi-Quantitative Determination of
Biofilm Formation
Semi-quantitative determination of biofilm formation were
performed as previously described (Christensen et al., 1985).
P. aeruginosa PA0643, PA0644, and PA0646 mutants were
tested in the biofilm-forming capacities in Minimum medium
supplemented with 5 mM citrate. The determination of biofilm
production was performed after 2, 4, and 6 h of growth by
dissolving crystal violet from the biofilm with an ethanol-acetone
mixture (70:30) and the absorbance measure at 590 nm.
Motility Assays
Assays were carried out to determine the effect of the PA0643,
PA0644, and PA0646 deletion gene on swimming, twitching and
swarming. For swimming assays, bacteria were placed with the
help of a sterile tooth-pick at the center of plates containing
a 5 mm layer of LB medium with 0.3% (w/v) Bacto agar,
0.2% casamino acids (w/v), and 30 mM glucose. Plates were
incubated at 37◦C for 24 h and the radial diffusion of bacteria,
due to swimming, was inspected. To monitor twitching motility,
bacteria were placed with a toothpick into a 2 mm thick layer
containing 1.5% (w/v) Bacto agar, 0.2% (w/v) casamino acids,
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TABLE 3 | Transcript levels that were increased in the presence of both, inulin and FOS.
Gene Id Gene Protein Function Inulin FOS
Log2 fold change p-value (10−6) Log2 fold change p-value (10−6)
PA0003 recF DNA replication and repair protein 1.8 0.000 1.2 0.000
PA0019 def Peptide deformylase 1.0 0.000 0.8 0.000
PA0026 plcB Phospholipase C 0.7 0.005 0.6 0.007
PA0408 pilG Twitching motility protein 0.8 0.000 0.8 0.000
PA0576 rpoD RNA polymerase sigma factor 0.6 0.000 0.7 0.000
PA0577 dnaG DNA primase 0.6 0.002 0.5 0.003
PA0668 tyrZ Tyrosyl-tRNA synthetase 2 0.9 0.000 0.7 0.000
PA0691 phdA Prevent-host-death protein A 1.6 0.000 1.3 0.000
PA0692 pdtB Phosphate depletion regulated TPS partner B 1.2 0.000 1.1 0.000
PA0693 exbB2 Transport protein 1.1 0.000 1.1 0.000
PA0730 3-hydroxyacyl-CoA-acyl carrier protein transferase. 0.8 0.000 0.6 0.004
PA0762 algU RNA polymerase sigma factor 0.6 0.001 0.6 0.000
PA0768 lepB Signal peptidase I 0.7 0.002 0.6 0.004
PA0782 PutA Proline dehydrogenase 0.6 0.002 0.5 0.006
PA0805 Uncharacterized protein 1.2 0.000 1.2 0.000
PA0826 Uncharacterized protein 0.8 0.000 0.7 0.000
PA0842 Probable glycosyl transferase 0.6 0.007 0.6 0.005
PA0896 aruF Arginine N-succinyltransferase 0.6 0.001 0.5 0.001
PA0979 Uncharacterized protein 1.2 0.000 1.0 0.000
PA1077 flgB Flagellar basal body rod protein FlgB 0.6 0.007 0.6 0.004
PA1081 flgF Flagellar basal-body rod protein FlgF 0.9 0.000 0.7 0.000
PA1084 flgl Flagellar P-ring protein 0.6 0.000 0.5 0.002
PA1327 Serine protease 0.9 0.000 0.8 0.000
PA1382 xqhB Probable type II secretion system protein 0.6 0.003 0.6 0.004
PA1414 Uncharacterized protein 1.9 0.001 1.7 0.004
PA1606 Uncharacterized protein 0.9 0.000 0.7 0.000
PA1608 Probable chemotaxis transducer 1.1 0.000 0.8 0.000
PA1610 fabA Beta-hydroxydecanoyl-ACP dehydrase 0.8 0.000 0.8 0.000
PA1673 Uncharacterized protein 1.7 0.000 1.3 0.000
PA1796 folD Cyclohydrolase 0.6 0.002 0.7 0.001
PA2022 UDP-glucose 6-dehydrogenase 1.0 0.000 0.9 0.000
PA2428 Uncharacterized protein 1.1 0.000 1.0 0.000
PA2548 Uncharacterized protein 0.8 0.000 0.9 0.000
PA2667 mvaU Biosynthetic process 0.5 0.012 0.6 0.001
PA2738 himA Integration host factor subunit alpha 0.7 0.000 0.8 0.000
PA2882 Probable two-component sensor 0.8 0.001 1.0 0.000
PA2971 yceD Uncharacterized protein 1.0 0.000 0.6 0.003
PA3019 uup Probable ATP-binding component of ABC transporter 0.8 0.000 0.6 0.002
PA3116 Probable aspartate-semialdehyde dehydrogenase 0.6 0.003 0.5 0.008
PA3147 wbpJ Probable glycosyl transferase 0.7 0.001 0.7 0.000
PA3181 edaA 2-dehydro-3-deoxy-phosphogluconate aldolase 1.1 0.000 1.4 0.000
PA3183 zwf Glucose-6-phosphate 1-dehydrogenase 1.7 0.000 2.0 0.000
PA3193 glk Glucokinase 0.6 0.004 0.7 0.002
PA3194 edd Phosphogluconate dehydratase 1.5 0.000 1.9 0.000
PA3195 gapA Glyceraldehyde-3-phosphate dehydrogenase 1.0 0.001 1.1 0.000
PA3219 Uncharacterized protein 1.2 0.000 1.3 0.000
PA3280 oprO Pyrophosphate-specific outer membrane porin 1.1 0.000 1.1 0.000
PA3296 phoA Alkaline phosphatase 0.6 0.005 0.6 0.007
PA3305 Uncharacterized protein 2.3 0.001 1.9 0.004
PA3351 flgM Two-component system 0.6 0.009 0.7 0.000
PA3382 phnE Phosphonate transport protein 0.6 0.004 0.7 0.001
PA3383 phnD Binding protein component of ABC phosphonate transporter 0.7 0.000 0.6 0.001
(Continued)
Frontiers in Microbiology | www.frontiersin.org 6 February 2020 | Volume 11 | Article 202
fmicb-11-00202 February 19, 2020 Time: 15:4 # 7
Rubio-Gómez et al. Transcriptomic Response to FOS Prebiotic
TABLE 3 | Continued
Gene Id Gene Protein Function Inulin FOS
Log2 fold change p-value (10−6) Log2 fold change p-value (10−6)
PA3384 phnC Phosphonates import ATP-binding protein 0.9 0.000 0.9 0.000
PA3496 nd Uncharacterized protein 0.5 0.002 0.5 0.007
PA3560 fruA Phosphotransferase system transporter 1.1 0.000 1.3 0.000
PA3561 fruK 1-phosphofructokinase 1.8 0.000 1.8 0.000
PA3562 fruI Phosphotransferase system transporter enzyme I 2.0 0.000 2.0 0.000
PA3623 nd Uncharacterized protein 0.7 0.001 0.7 0.004
PA3744 rimM 16S rRNA processing protein 0.8 0.000 0.6 0.004
PA3746 ffh Signal recognition particle protein 0.6 0.002 0.5 0.004
PA3903 prfC Peptide chain release factor 3 0.9 0.000 0.7 0.001
PA3990 Uncharacterized protein 1.3 0.000 0.9 0.000
PA4255 rpmC 50S ribosomal protein L29 0.9 0.000 0.8 0.000
PA4264 rpsJ 30S ribosomal protein S10 0.7 0.001 0.6 0.004
PA4270 rpoB DNA-directed RNA polymerase beta chain 0.4 0.009 0.5 0.003
PA4280 birA Regulation of transcription 0.7 0.000 0.7 0.000
PA4378 InaA Protein of response to stimulus 1.0 0.000 0.6 0.000
PA4418 ftsI Peptidoglycan D.D-transpeptidase 1.1 0.000 0.9 0.000
PA4420 yabC Uncharacterized protein 0.5 0.009 1.0 0.000
PA4421 yabC Uncharacterized protein 1.2 0.000 1.1 0.000
PA4432 rpsI 30S ribosomal protein S9 0.7 0.012 0.8 0.000
PA4451 yrbA Uncharacterized protein 0.7 0.000 0.9 0.000
PA4462 rpoN RNA polymerase sigma-54 factor 0.9 0.000 0.6 0.000
PA4520 Probable chemotaxis transducer 0.4 0.009 0.5 0.003
PA4541 lepA Large extracellular protease 0.7 0.000 0.6 0.000
PA4602 glyA3 Serine hydroxymethyltransferase 1.0 0.000 0.9 0.000
PA4690 Uncharacterized protein 0.5 0.009 0.6 0.005
PA4723 dksA Suppressor protein 1.0 0.000 0.9 0.000
PA4741 rpsO 30S ribosomal protein S15 0.6 0.001 0.9 0.000
PA4747 secG Secretion protein 0.6 0.003 0.7 0.001
PA4844 ctpL Methyl-accepting chemotaxis protein 0.7 0.001 0.6 0.002
PA4853 fis Putative Fis-like DNA-binding protein 0.7 0.006 1.0 0.000
PA4945 miaA Delta 2-isopentenylpyrophosphate 0.8 0.000 0.6 0.004
PA4960 serB Probable phosphoserine phosphatase 0.9 0.000 0.7 0.000
PA4961 Uncharacterized protein 0.7 0.000 0.7 0.000
PA4963 Uncharacterized protein 0.8 0.001 0.7 0.002
PA5013 ilvE Branched-chain-amino-acid transferase 0.7 0.001 0.8 0.000
PA5015 aceE Pyruvate dehydrogenase 0.7 0.001 0.6 0.005
PA5042 pilO Type 4 fimbrial biogenesis protein 1.0 0.000 0.9 0.000
PA5045 ponA Penicillin-binding protein 1A 1.3 0.000 1.0 0.000
PA5058 phaC2 Poly(3-hydroxyalkanoic acid) synthase 2 0.8 0.000 1.0 0.000
PA5066 hisI Phosphoribosyl-AMP cyclohydrolase 0.6 0.000 0.5 0.005
PA5152 Probable ATP-binding component of ABC transporter 0.6 0.001 0.6 0.001
PA5170 arcD Arginine/ornithine antiporter 0.7 0.000 0.6 0.000
PA5208 Uncharacterized protein 0.5 0.004 0.4 0.008
PA5235 glpT Glycerol-3-phosphate transporter 1.0 0.000 0.9 0.000
PA5285 sutA Uncharacterized protein 0.6 0.003 0.6 0.002
PA5286 yjbQ Uncharacterized protein 0.7 0.002 0.7 0.003
PA5301 pauR Polyamine catabolic process 0.7 0.002 0.6 0.002
PA5315 rpmG 50S ribosomal protein L33 0.6 0.002 0.6 0.001
PA5332 crc Catabolite repression control protein 1.1 0.000 0.8 0.004
PA5348 nd Probable DNA-binding protein 0.6 0.010 0.7 0.005
PA5367 pstA Phosphate ABC transporter 0.9 0.005 1.2 0.000
PA5369 pstS Phosphate ABC transporter 0.8 0.000 0.5 0.006
PA5435 oadA Probable transcarboxylase activity 0.6 0.002 0.9 0.000
The above table shows the list of the significant up regulated genes and control with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.
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FIGURE 3 | Functional comparison of differentially expressed genes in the presence of FOS and inulin as compared to the control. Functions are organized into three
groups: Cellular components, Molecular Function, and Biological Process. The functional groups with the main differences between FOS and inulin are “Molecular
transducer,” “Biological adhesion” “Developmental process” and “locomotion system.”
and 30 mM glucose. After incubation at 37◦C for 24 h, the
expansion of bacteria on the plate was observed. For swarming
assays, 5 µl of an overnight culture of bacteria were placed in
the center of swarm plates, which are made of 0.5% (w/v) Bacto
agar supplemented with 0.2% (w/v) casamino acids and 30 mM
glucose. Plates were incubated at 37◦C for 24 h, followed by an
inspection of the surface movement of the bacteria. All motility
assays were performed in triplicate.
Statistical Analysis
All results are expressed as means from three cultures with
the corresponding standard deviations. Data were analyzed for
statistical significance using the one-way ANOVA analysis and
a posteriori least significance test. All analyses were carried
out with the SigmaStat 2.03 program (Jandel Corporation, San
Rafael, CA, United States). Fitting of dose-response curves was
done using Origin 7.0 (OriginLab Corporation, Northampton,
MA, United States). Differences were considered significant
at p < 0.05.
RESULTS
FOS and Inulin Induce Differential
Changes in Pseudomonas aeruginosa
Transcript Levels
To understand the cellular response of P. aeruginosa PAO1
to FOS and inulin treatment, we conducted RNA-seq studies.
Transcriptomic changes were determined in duplicate cultures
grown in the absence and in the presence of either FOS or
inulin at final concentrations of 20 mg/ml. Between 5,300,000
and up to 7,500,000 reads were obtained for inuline and FOS
respectively, of which approximately 85% could be assigned to
the 6,322 coding regions of the P. aeruginosa PAO1 reference
genome (Table 1).
The heat map shown in Figure 1A illustrates genes with the
most important alterations in transcript levels in the presence of
FOS/inulin as compared to the control. For both compounds the
number of genes with increased transcript levels were superior
to those with decreased levels (see Figure 1B). FOS and inulin
induced changes in the transcript level of 217 and 258 genes
respectively, compared to the control to which no polysaccharide
was added (Figure 2). Importantly, down changes in transcript
levels of 57 and 83 genes were found to be specific for inulin
or FOS, respectively (Figure 2A). Moreover, 201 and 134 genes
showed an increase in transcript levels by inulin and FOS,
respectively (Figure 2B) indicating that both compounds trigger
different changes.
Supplementary Tables S1 and S2 show the list of genes for
which the expression level significantly increased or decreased in
the presence of 20 mg/ml of inulin (Supplementary Table S1)
and FOS (Supplementary Table S2). Analysis of the expression
pattern showed that only 22 genes had decreased levels in the
presence of both compounds (Figure 2A and Table 2). Among
these genes the most prominent changes were observed for
genes involved in: (1) Organic acid transport such as PA1342
(aatj), which encodes a C4-dicarboxylate transport protein
and PA1183 (dctA), (2) Central metabolism, like a PA0795
(prpC), which regulates a citrate synthase, PA2008 (fahA) that
controls a fumarylacetoacetase, and PA1585 (sucA) encoding
a 2- oxoglutatate dehydrogenase, (3) Oxidative stress such as
superoxide dismutase PA4366 and (4) Virulence system like
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TABLE 4 | Genes with reduced transcript levels following exposure to FOS treatment.
Gene ID Gene Protein Function log2 Fold Change p-value (10−6)
PA0049 Uncharacterized protein −1.2 0.001
PA0090 clpV1 Type VI secretion ATPase* −0.8 0.000
PA0296 spuI Glutamylpolyamine synthetase −0.6 0.007
PA0612 ptrB Positive regulation of cellular biosynthetic process −0.9 0.002
PA0613 Uncharacterized protein −1.3 0.000
PA0614 Uncharacterized protein −1.1 0.000
PA0615 Uncharacterized protein −1.3 0.000
PA0616 Uncharacterized protein −2.5 0.000
PA0617 Uncharacterized protein −2.1 0.000
PA0618 Uncharacterized protein −1.9 0.000
PA0619 Uncharacterized protein −2.4 0.000
PA0620 Uncharacterized protein −2.5 0.000
PA0621 Uncharacterized protein −3.2 0.000
PA0622 Uncharacterized protein −2.5 0.000
PA0623 Uncharacterized protein −2.3 0.000
PA0624 Uncharacterized protein −2.3 0.000
PA0625 Uncharacterized protein −2.5 0.000
PA0626 Uncharacterized protein −2.1 0.000
PA0627 Uncharacterized protein −3.7 0.000
PA0628 Uncharacterized protein −2.9 0.000
PA0629 Uncharacterized protein −2.6 0.000
PA0630 Uncharacterized protein −1.8 0.000
PA0631 Uncharacterized protein −2.9 0.000
PA0632 Uncharacterized protein −2.1 0.000
PA0633 Uncharacterized protein −2.2 0.000
PA0634 Uncharacterized protein −1.5 0.000
PA0635 Uncharacterized protein −1.9 0.000
PA0636 Uncharacterized protein −2.5 0.000
PA0637 Uncharacterized protein −2.8 0.000
PA0638 Uncharacterized protein −2.6 0.000
PA0639 Uncharacterized protein −2.5 0.000
PA0640 Uncharacterized protein −2.1 0.000
PA0641 Uncharacterized protein −2.1 0.000
PA0642 Uncharacterized protein −2.2 0.000
PA0643 Uncharacterized protein −2.2 0.000
PA0644 Uncharacterized protein −2.0 0.000
PA0645 Uncharacterized protein −1.9 0.000
PA0646 Uncharacterized protein −1.5 0.000
PA0647 Uncharacterized protein −1.3 0.000
PA0795 Uncharacterized protein −0.9 0.002
PA0807 ampD N-acetylmuramoyl-L-alanine amidase −2.7 0.000
PA0809 Transporter activity −1.7 0.000
PA0811 Transmembrane transport −1.8 0.000
PA0812 Uncharacterized protein −1.7 0.000
PA0908 alpB Response to antibiotic −2.0 0.000
PA0910 alpD Response to DNA damage stimulus −1.7 0.000
PA0911 alpE Response to DNA damage stimulus −1.4 0.000
PA0912 Uncharacterized protein −2.4 0.000
PA1069 Uncharacterized protein −0.5 0.003
PA1171 sltB2 Soluble lytic transglycolase −0.6 0.008
PA1183 dctA C4-dicarboxylate transport protein −1.2 0.000
PA1337 ansB Glutaminase-asparaginase −0.9 0.002
PA1342 aatj Probable binding protein component of ABC transport −1.1 0.000
PA1585 sucA 2-oxoglutarate dehydrogenase −0.6 0.001
PA1588 sucC Succinyl-CoA synthetase −0.6 0.002
(Continued)
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TABLE 4 | Continued
Gene ID Gene Protein Function log2 Fold Change p-value (10−6)
PA1592 nd Uncharacterized protein −0.8 0.001
PA1787 acnB Aconitrate hydratase B −0.5 0.003
PA2001 atoB Acetyl-CoA acetyltransferase −1.0 0.002
PA2007 maiA Maleylacetatoacetate isomerase −0.7 0.003
PA2008 fahA Fumarylacetoacetase −1.1 0.000
PA2040 pauA4 Glutamylpolyamine synthetase −0.7 0.002
PA2111 Uncharacterized protein −1.1 0.000
PA2247 bkdA1 2-oxoisovalerate dehydrogenase −0.7 0.004
PA2796 tal Transaldolase −0.8 0.004
PA3661 Uncharacterized protein −1.0 0.001
PA3692 lptF Lipotoxon F −0.8 0.006
PA3866 Pyocin S4 −1.0 0.000
PA4055 ribC Riboflavin synthase −0.7 0.005
PA4237 rplQ 50S ribosomal protein L17 −0.6 0.005
PA4239 rpsD 30S ribosomal protein S4 −0.6 0.001
PA4240 rpsK 30S ribosomal protein S11 −1.0 0.000
PA4274 rplk 50S ribosomal protein L11 −0.7 0.002
PA4366 sodB Superoxide dismutase −0.7 0.000
PA4370 icmP Insulin-cleaving metalloproteinase outer membrane protein −0.9 0.000
PA4430 probable cytochrome b −0.6 0.003
PA4578 Uncharacterized protein −0.8 0.000
PA4774 Uncharacterized protein −0.7 0.001
PA4823 Uncharacterized protein −1.2 0.000
PA4824 Uncharacterized protein −0.8 0.000
PA4825 mgtA Mg(2+) transport ATPase P-type 2 −0.8 0.000
PA4826 Uncharacterized protein −0.5 0.005
PA5149 mviM Uncharacterized protein −1.0 0.005
PA5169 dctM C4-dicarboxylate transport −1.0 0.001
The above table shows the list of the significant up regulated genes with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.
the Type VI secretion ATPase (PA0090). These genes were
outnumbered by the genes for which both compounds caused an
increase in transcript levels (Figure 2 and Table 3).
A significant number of these genes appear to be involved
in sensing (transcriptional regulators, sensor kinases, and
chemotaxis transducers), motility, glucose metabolism as well
as control of transcription and protein synthesis (Figure 2
and Table 3).
Functional Analysis of Pseudomonas
aeruginosa Transcriptome Following
Exposure to FOS and Inulin
GO terms (WEGO) enrichment analyses were conducted to
characterize the DEG (Differentially expressed genes) profiles and
K-means clustering was performed to further investigate their
biological function. We found that the differentially expressed
genes can be classified into 32 categories that belonged to three
gene ontology (GO) categories, i.e., the biological process, the
cellular component or the molecular function (Figure 3). There
were more genes classified into biological processes than the
other two categories and most genes were predicted to have a
binding function, as these genes are primarily involved in protein
metabolism (Figure 3).
The over-expressed DEGs were assigned to 15 GO categories
based on biological processes (Figure 3) and the results showed
that the response to the stimulus, metabolic process, biological
regulation, the establishment of localization and pigmentation
were among the most highly represented groups in the biological
process category in the presence of inulin or FOS. However,
“biological adhesion” and “developmental process” showed a
drastic decrease in the number of genes between inulin or FOS
samples. While in the “locomotion process” most of the inhibited
genes (43%) are annotated in FOS samples (Figure 3).
Furthermore, DEGs were assigned to seven GO categories
based on cellular component and the result showed that “Cell”
and “Cell part” are similar and highly represented groups for
FOS and inulin samples (Figure 3). However, the “extracellular
region” and the “organelle part” are lower and distinctly
represented in the presence of inulin or FOS (Figure 3).
Genes with altered transcript levels could be grouped
into 10 GO terms with different molecular functions of
which the categories “antioxidant,” “binding,” “electron
carrier,” “transcription regulator,” “structural molecular”, and
“transcription regulator” were most populated (Figure 3).
It is worth noting that, in the “molecular transducer”
category a significantly higher number of genes were noted
for inulin as compared to FOS. The individual genes that
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TABLE 5 | Genes with increased transcript levels following exposure to FOS treatment.
Gene ID Gene Protein Log2 fold Change p-value (10−6)
PA0003 recF DNA replication and repair protein 1.2 0.000
PA0019 def Peptide deformylase 0.8 0.000
PA0026 plcB Phospholipase C 0.6 0.007
PA0408 pilG Twitching motility protein 0.8 0.000
PA0576 rpoD RNA polymerase sigma factor 0.7 0.000
PA0577 dnaG DNA primase 0.5 0.003
PA0668 tyrZ Tyrosyl-tRNA synthetase 2 0.7 0.000
PA0691 phdA Prevent-host-death protein A 1.3 0.000
PA0692 pdtB Phosphate depletion regulated TPS partner B 1.1 0.000
PA0693 exbB2 Transport protein 1.1 0.000
PA0695 Uncharacterized protein 1.2 0.000
PA0715 Uncharacterized protein 0.6 0.007
PA0730 3-hydroxyacyl-CoA-acyl carrier protein transferase. 0.6 0.004
PA0762 algU RNA polymerase sigma factor 0.6 0.000
PA0768 lepB Signal peptidase I 0.6 0.004
PA0782 putA Proline dehydrogenase 0.5 0.006
PA0805 Uncharacterized protein 1.2 0.000
PA0826 Uncharacterized protein 0.7 0.000
PA0842 Probable glycosyl transferase 0.6 0.005
PA0896 aruF Arginine N-succinyltransferase 0.5 0.001
PA0952 Uncharacterized protein 1.1 0.001
PA0979 Uncharacterized protein 1.0 0.000
PA1077 flgB Flagellar basal body rod protein FlgB 0.6 0.004
PA1081 flgF Flagellar basal-body rod protein FlgF 0.7 0.000
PA1084 flgl Flagellar P-ring protein 0.5 0.002
PA1327 Serine protease 0.8 0.000
PA1382 xqhB Probable type II secretion system protein 0.6 0.004
PA1414 Uncharacterized protein 1.7 0.004
PA1606 Uncharacterized protein 0.7 0.000
PA1608 Probable chemotaxis transducer 0.8 0.000
PA1610 fabA Beta-hydroxydecanoyl-ACP dehydrase 0.8 0.000
PA1673 Uncharacterized protein 1.3 0.000
PA1796 folD Cyclohydrolase 0.7 0.001
PA1803 lon Protein secretion by the type III secretion system 0.5 0.003
PA2022 UDP-glucose 6-dehydrogenase 0.9 0.000
PA2426 pvdS Sigma factor 1.2 0.001
PA2428 Uncharacterized protein 1.0 0.000
PA2461 Uncharacterized protein 0.7 0.008
PA2548 Uncharacterized protein 0.9 0.000
PA2637 nuoA NADH dehydrogenase I 0.6 0.004
PA2667 mvaU Biosynthetic process 0.6 0.001
PA2685 vgrG4 protein secretion system type VI 0.5 0.005
PA2696 probable transcriptional regulator 1.0 0.004
PA2738 himA Integration host factor subunit alpha 0.8 0.000
PA2756 Uncharacterized protein 0.7 0.000
PA2882 Probable two-component sensor 1.0 0.000
PA2971 yceD Uncharacterized protein 0.6 0.003
PA3019 uup Probable ATP-binding component of ABC transporter 0.6 0.002
PA3116 Probableaspartate-semialdehyde dehydrogenase 0.5 0.008
PA3147 wbpJ Probable glycosyl transferase 0.7 0.000
PA3161 him Integration host factor 0.6 0.005
PA3181 eda 2-dehydro-3-deoxy-phosphogluconate aldolase 1.4 0.000
PA3182 pgl 6-phosphogluconolactonase 2.0 0.000
PA3183 zwf Glucose-6-phosphate 1-dehydrogenase 2.1 0.000
(Continued)
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TABLE 5 | Continued
Gene ID Gene Protein Log2 fold Change p-value (10−6)
PA3190 gltB Component of ABC sugar transporter 0.8 0.004
PA3192 gltR Two-component response regulator 1.6 0.000
PA3193 glk Glucokinase 0.7 0.002
PA3194 edd Phosphogluconate dehydratase 1.9 0.000
PA3195 gapA Glyceraldehyde-3-phosphate dehydrogenase 1.1 0.000
PA3219 Uncharacterized protein 1.3 0.000
PA3262 Peptidyl-prolyl cis-trans isomerase 0.8 0.001
PA3280 oprO Pyrophosphate-specific outer membrane porin 1.1 0.000
PA3296 phoA Alkaline phosphatase 0.6 0.007
PA3305 Uncharacterized protein 1.9 0.004
PA3345 hptB Histidine phosphotransfer protein 0.5 0.008
PA3351 flgM Two-component system 0.7 0.000
PA3382 phnE Phosphonate transport protein 0.7 0.001
PA3383 phnD Binding protein component of ABC phosphonate transporter 0.6 0.001
PA3384 phnC Phosphonates import ATP-binding protein 0.9 0.000
PA3496 Uncharacterized protein 0.5 0.007
PA3560 fruA Phosphotransferase system transporter 1.3 0.000
PA3561 fruK 1-phosphofructokinase 1.8 0.000
PA3562 fruI Phosphotransferase system transporter enzyme I. 2.0 0.000
PA3563 Uncharacterized protein 0.7 0.004
PA3623 Uncharacterized protein 0.6 0.002
PA3744 rimM 16S rRNA processing protein 0.6 0.004
PA3746 ffh Signal recognition particle protein 0.5 0.004
PA3903 prfC Peptide chain release factor 3 0.7 0.001
PA3990 Uncharacterized protein 0.9 0.000
PA4255 rpmC 50S ribosomal protein L29 1.1 0.000
PA4264 rpsJ 30S ribosomal protein S10 0.8 0.000
PA4270 rpoB DNA-directed RNA polymerase beta chain 0.9 0.000
PA4280 birA Regulation of transcription 0.6 0.000
PA4335 Uncharacterized protein 1.1 0.001
PA4336 Uncharacterized protein 0.8 0.003
PA4378 inaA Protein of response to stimulus 0.6 0.004
PA4418 ftsI Peptidoglycan D.D-transpeptidase 0.5 0.003
PA4420 yabC Uncharacterized protein 0.6 0.000
PA4421 yabC Uncharacterized protein 0.9 0.000
PA4432 rpsI 30S ribosomal protein S9 0.6 0.005
PA4451 yrbA Uncharacterized protein 0.9 0.000
PA4462 rpoN RNA polymerase sigma-54 factor 0.9 0.000
PA4475 Uncharacterized protein 0.7 0.001
PA4520 Probable chemotaxis transducer 0.6 0.002
PA4525 pilA Type 4 fimbrial precursor 0.9 0.000
PA4541 lepA Large extracellular protease 1.0 0.000
PA4545 comL Outer membrane lipoprotein 0.6 0.003
PA4602 glyA3 Serine hydroxymethyltransferase 0.6 0.004
PA4611 Uncharacterized protein 0.6 0.008
PA4690 Uncharacterized protein 1.1 0.000
PA4723 dksA Suppressor protein 0.7 0.000
PA4741 rpsO 30S ribosomal protein S15 0.7 0.002
PA4747 secG Secretion protein 0.8 0.000
PA4844 ctpL Chemoreceptor for inorganic phosphate 0.6 0.005
PA4853 fis Putative Fis-like DNA-binding protein 0.9 0.000
PA4941 hflC Protease 0.5 0.004
PA4944 hfq Motilities and Quorum sensing 0.6 0.001
PA4945 miaA Delta 2-isopentenylpyrophosphate 1.0 0.000
(Continued)
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TABLE 5 | Continued
Gene ID Gene Protein Log2 fold Change p-value (10−6)
PA4960 serB Probable phosphoserine phosphatase 0.6 0.003
PA4961 Uncharacterized protein 0.5 0.005
PA4963 Uncharacterized protein 0.6 0.001
PA5013 ilvE Branched-chain-amino-acid transferase 0.6 0.000
PA5015 aceE Pyruvate dehydrogenase 0.4 0.008
PA5040 pilQ Type IV pilus-dependent motility 0.5 0.004
PA5042 pilO Type IV pilus-dependent motility 0.9 0.000
PA5043 pilN Type IV pilus-dependent motility 0.7 0.005
PA5045 ponA Penicillin-binding protein 1A 0.6 0.002
PA5058 phaC2 Poly(3-hydroxyalkanoic acid) synthase 2 0.7 0.003
PA5066 hisI Phosphoribosyl-AMP cyclohydrolase 0.6 0.002
PA5152 Probable ATP-binding component of ABC transporter 0.6 0.001
PA5170 arcD Arginine/ornithine antiporter 0.8 0.004
PA5208 Uncharacterized protein 0.7 0.005
PA5235 glpT Glycerol-3-phosphate transporter 1.2 0.000
PA5255 algQ Alginate regulatory protein 0.6 0.007
PA5285 sutA Uncharacterized protein 0.5 0.006
PA5286 yjbQ Uncharacterized protein 0.7 0.000
PA5288 glnK Nitrogen regulatory protein 0.6 0.003
PA5301 pauR Polyamine catabolic process 0.9 0.000
PA5315 rpmG 50S ribosomal protein L33 0.7 0.000
PA5332 crc Catabolite repression control protein 0.7 0.000
PA5348 Probable DNA-binding protein 0.7 0.001
PA5367 pstA Phosphate ABC transporter 0.7 0.001
PA5369 pstS Phosphate ABC transporter 0.7 0.000
PA5435 oadA Probable transcarboxylase activity 0.9 0.000
The above table shows the list of the significant up regulated genes with a log2 fold change cut off ≥ 0.5 by taking significant p-value < 0.05.
were classified into these different GO terms are provided in
Supplementary Tables S1, S2.
Differential Gene Expression Pattern in
the Presence of FOS
The differential expression analysis performed with DESeq2
in the presence of FOS showed that 83 gene transcript
levels were reduced (Table 4), whereas 134 were increased
(Figure 2 and Table 5). A large number of genes with reduced
transcript levels (43%) were annotated as hypothetical proteins
of uncharacterized functions (Table 4). We observed a decrease
in the expression of genes related to (1) Metabolic pathways
like citrate synthase (prpC), glutaminase-asparaginase (ansB),
glutamylpolyamine synthetase (pauA4), and riboflavin synthase
(ribC), (2) Transport systems such as PA0811 and PA1342 (aatj)
(3) Translation cellular processes like several ribosomal proteins
(rplQ, rpsD, rpsK, and rplK) and (4) Virulence such as PA0090
(clpV); PA0612 (ptrB), PA3866 (pyocin S4), and PA4370 (icmP)
(see Table 4).
Surprisingly, in addition to increasing the expression of genes
involved in different metabolic pathways necessary for bacterial
growth, we found that transcript levels of many genes that
are related to P. aeruginosa motility were increased in the
presence of FOS (Table 5), exemplified by genes involved in
twitching motility (pilG), components of the flagellar motor or
chemoreceptors including CtpL that mediates specific taxis to
inorganic phosphate – a key regulator of P. aeruginosa virulence
(Zaborin et al., 2009; Bains et al., 2012). In the same manner,
transcript levels of many genes associated within the glucose
metabolism were also increased including genes eda, zwf, gapA,
glk, edd, or gltR (Table 5) suggesting that P. aeruginosa can
catabolize these compounds.
Effect of FOS on Virulence Related Gene
Transcript Levels
All the DEGs were mapped to KO terms in the KEGG
database to identify FOS modulated genes that play
a role in bacterial virulence, motility, or sensitivity to
antibiotics and the corresponding genes are provided
in Table 6.
Noteworthy are the increases observed for transcript
levels of PA0668 which encodes a TyrZ: Tyrosyl-tRNA
synthetase2 that inhibits growth and biofilm formation
(Williams-Wagner et al., 2015), genes of the pilMNOPQ operon,
which are important for the pilus assembly system (T4P) and
promote surface-associated attachment (Ayers et al., 2009;
Tammam et al., 2013; McCallum et al., 2016) showed increased
transcript levels like pilG (PA0408) (Log2 fold = 0.8); pilQ
(PA5040) (0.5 Log2 fold); pilO (PA5042) (0.9 Log2 fold);
pilN (PA5043) (0.7 Log2 fold); or different genes of the flg
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TABLE 6 | Genes with increased transcript levels in response to FOS that are related to bacterial pathogenicity.
Gene ID Gene Protein Log2 Fold Change Function References
PA0408 pilG Twitching motility protein 0.81 Twitching motility and
Chemotaxis
Darzins, 1993; Darzins and
Russell, 1997; Whitchurch
et al., 2004
PA0668 tyrZ Tyrosyl-tRNA synthetase 2 0.7 Inhibit growth and biofilm
formation
Williams-Wagner et al., 2015
PA0692 pdtB Phosphate depletion regulated
TPS partner B
1.1 Type V secretion system Faure et al., 2014
PA0762 algU RNA polymerase sigma factor 0.6 Control expression of virulence
genes
Stacey and Pritchett, 2016;
Stacey et al., 2017
PA1077 flgB Flagellar basal-body rod protein 0.63 Bacterial-type
flagellum-dependent cell
motility
Goodier and Ahmer, 2001
PA1081 flgF Flagellar basal-body rod protein
FlgF
0.75 Flagellar assembly Goodier and Ahmer, 2001
PA1084 flgI Flagellar P-ring protein 0.54 Flagellar assembly Goodier and Ahmer, 2001
PA1382 xqhB Probable type II secretion
system protein
0.6 Type II secretion system Stover et al., 2000
PA1608 Probable chemotaxis
transducer
0.8 Chemotaxis system and biofilm
formation
Southey-Pillig et al., 2005





Udaondo et al., 2018
PA3192 gltR Two component system 1.6 Carbohydrate metabolic and
virulence
Daddaoua et al., 2014
PA3351 flgM Negative regulator of flagellin
synthesis FlgM
0.73 Flagellar assembly Goodier and Ahmer, 2001
PA4520 Chemotaxis transducer 0.6 Chemotaxis system Victoria et al., 2003
PA4747 secG Secretion protein 0.7 Sec secretory pathway Crowther et al., 2015
PA4844 ctpL Chemoreceptor for inorganic
phosphate
0.6 Chemotaxis to inorganic
phosphate
Rico-Jiménez et al., 2016
PA5040 pilQ Type 4 fimbrial biogenesis
protein
0.5 Surface filaments involved in
host colonization
Darzins, 1993; Darzins and
Russell, 1997; Whitchurch
et al., 2004
PA5042 pilO Type 4 fimbrial biogenesis
protein
0.9 Surface filaments involved in
adhesion cell, twitching motility
Martin et al., 1995; Leighton
et al., 2018; Ayers et al., 2009
PA5043 pilN Type 4 fimbrial biogenesis
protein
0.7 Surface filaments involved in
host colonization
Ayers et al., 2009
PA5045 ponA Penicillin-binding protein 1A 1.0 ampR-β-lactamase modulation Handfield et al., 1997
PA5332 crc Catabolite repression control
protein
0.8 Virulence, Quorum Sensing Milojevic et al., 2013;
Chakravarthy et al., 2017
PA5435 oadA Probable transcarboxylase
activity
0.9 Virulence Bains et al., 2012
PA5369 pstS Phosphate ABC transporter
transporter control protein
0.8 Virulence Zaborin et al., 2009
operon that encode proteins of the flagellar motor such as
flgB (PA1077) (0.6 Log2 fold); flgF (PA1081) (0.7 Log2 fold);
flgI (PA1084) (0.5 Log2 fold); and flgM (PA3351) (0.7 Log2
fold). Moreover, the transcript levels of three chemoreceptors
were increased in the presence of FOS, of which two (PA1608,
PA4520) are of unknown function, whereas PA4844 (ctpl)
encodes a specific chemoreceptor for inorganic phosphate
(Rico-Jiménez et al., 2016). In addition, the zwf1 gene encoding
a glucose-6-phosphate dehydrogenase that is involved in
P. aeruginosa virulence (Udaondo et al., 2018) showed much
higher transcript levels (2.13 Log2 fold) in the presence of
FOS. In the same manner, transcript levels of gltR encoding
the response regulator of the GtrS/GltR two component
system (TCS) were significantly increased (1.6 Log2 fold)
(Table 6). This TCS was found to regulate the expression
of toxA encoding the primary virulence factor exotoxin A
(Udaondo et al., 2018).
However, the results (Table 7) show several virulence
related genes with reduced transcript levels, such as PA0090
encoding the ClpV1 protein, involved in the type VI secretion
system (Bönemann et al., 2009), or the PtrB component of
the type III secretion system (TTSS) that coordinates TTSS
repression and pyocin synthesis under DNA damage (Weihui and
Shouguang, 2005). The latter observation agrees with the reduced
Frontiers in Microbiology | www.frontiersin.org 14 February 2020 | Volume 11 | Article 202
fmicb-11-00202 February 19, 2020 Time: 15:4 # 15
Rubio-Gómez et al. Transcriptomic Response to FOS Prebiotic
TABLE 7 | Genes with decreased transcript levels in response to FOS that are related to bacterial pathogenicity.
Gene ID Gene Protein Fold change Function References
PA0090 clpV Type VI secretion ATPase −0.84 Biofilm formation and secretion system
type VI
Bönemann et al., 2009
PA0296 spuI Glutamylpolyamine synthetase −0.55 Polyamine toxicity Dong-Kwon and Chung-Dar,
2006
PA0612 ptrB Protease −0.85 Suppresses the Type III Secretion
System
Weihui and Shouguang, 2005
PA0807 ampD N-acetylmuramoyl-L-alanine amidase −2.68 β-lactam resistance Amber and Nancy Hanson, 2008
PA0908 alpB Outer membrane protein AlpB −1.98 Cellular response to antibiotic Alvarez-Ortega et al., 2010
PA1183 dctA C4-dicarboxylate transport protein −1.23 Growth process Valentini et al., 2011
PA3692 lptF Lipotoxon F −0.78 Integral component of membrane and
survival factor
Heath-Damron et al., 2009
PA3866 Pyocin S4, soluble (S-type) pyocins −0.95 Virulence factor Ameer et al., 2012
PA4370 icmP Insulin-cleaving metalloproteinase outer membrane
protein precursor
−0.93 Pathogenicity Christian et al., 2015
TABLE 8 | Quantitative real time PCR experiments to quantify the effect of FOS on
the transcript levels of genes that belong to the genomic island and that are
related to bacterial pathogenicity in P. aeruginosa.







PA0908 alpB Outer membrane protein AlpB −5.8 0.04
PA1183 dctA C4-dicarboxylate transport
protein
−7.2 0.02
PA0296 spuI Glutamylpolyamine synthetase −7.1 0.04





PA4844 ctpL Chemoreceptor for inorganic
phosphate
+ 0.65 0.09
Experiments were conducted using P. aeruginosa cultures grown in the presence
and absence of 20 mg/ml of FOS. The cycle threshold values were normalized to
that of the reference transcript, 16S RNA, and data of relative expression levels
were normalized to the control lacking FOS.
transcript level of the gene (PA3866) encoding the pyocin S4
(Ameer et al., 2012).
In addition, the results shown in Table 7 reveal reduced
transcript levels for PA3692 (lptF), encoding an outer membrane
protein (alipotoxon), which plays a key role in P. aeruginosa
survival under harsh environmental conditions, including lung
colonization in patients with cystic fibrosis (Heath-Damron
et al., 2009). Furthermore, the reduction in transcript levels for
PA0807 (ampD) and PA0908 (alpB), encoding proteins involved
in responses to antibiotics, or in PA0296, involved in polyamine
toxicity, may indicate that FOS modulates sensitivity to
antibiotics (Amber and Nancy Hanson, 2008; Shah and Swiatlo,
2008; Alvarez-Ortega et al., 2010) and polyamines (Dong-Kwon
and Chung-Dar, 2006). These data have been confirmed by real
time quantitative PCR (rt-qPCR) experiments (Table 8).
Moreover, FOS treatment resulted in lower transcript levels
of the dctA gene (PA1183) which is associated with the normal
FIGURE 4 | Quantitative RT-PCR validations of the effect of FOS and inulin on
the expression of secretion system genes. rt-qPCR studies of P. aeruginosa of
cultures grown in the presence and absence of 20 mg/ml inulin (A) or FOS
(B). The expression of genes encoding proteins of secretion systems III and VI
are shown. *P < 0.05 vs. Control.
growth of P. aeruginosa (Valentini et al., 2011) and of the icmP
gene (PA4370) encoding an metalloproteinase outer membrane
protein, which has been shown to degrade the plasminogen
activator (Christian et al., 2015) and plays a key role in the
Pseudomonas aeruginosa pathogenicity. These FOS mediated
alterations in transcript levels have been confirmed by rt-qPCR
studies (see Table 8). Altogether, data suggest that FOS acts
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FIGURE 5 | Location of the genomics island with genes widely repressed by FOS-treatment in Pseudomonas aeruginosa PAO1 genome. Figure were made using
IslandViewer4 (Bertelli et al., 2017). Genes ids with a red dot represent genes repressed in presence of FOS treatment. Genes with blue dot represent genes
identified in a genomic island in P. aeruginosa PAO1 genome.
as a signal molecule that modulates bacterial virulence through
distinct signaling pathways.
Confirmation That FOS Reduces
Expression of Structural Proteins of
Secretion System III and VI
To confirm that FOS mediates changes in secretion system
genes, we have conducted rt-qPCR experiments to determine the
influence of FOS and inulin on the expression of 4 genes that
encode proteins that are part of type III and VI secretion systems.
The products of the pcrV and exsA genes control the activation
of the type III secretion system (Lee et al., 2010), whereas the
proteins encoded by hcp1 and vgrG1 are necessary for the type
VI secretion system (Hachani et al., 2011).
We found that inulin caused a significant increase in pcrV and
exsA transcript levels, whereas those of hcp1 and vgrG1 did not
vary (Figure 4A). In contrast, the expression of exsA and hcp1
were dramatically down regulated by factors of approximately 20
and 7, respectively, in the presence of FOS (Figure 4B). FOS but
not inulin down regulated the expression of two components of
the type III and VI secretion system.
FIGURE 6 | The effect of PA0643, PA0644, and PA0646 deletion on the
growth of P. aeruginosa PAO1. Shown are results from growth experiments
that were conducted in M9 minimum medium at 37◦C for 24 h.
Representative data from one of three independent experiments with similar
results are shown.
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FIGURE 7 | The effect of PA0643, PA0644, and PA0646 deletion on biofilm
formation of P. aeruginosa PAO1. Biofilm formation was monitored in minimum
medium supplemented with 5 mM of citrate and quantified after 2, 4, and 6 h.
The OD at 590 nm of crystal violet (CV) stained and resuspended bacteria
from biofilms was recorded. Shown are means and standard deviations with
n = 3–6; *P < 0.05 vs. WT.
Identification of Genomics Islands
Widely Repressed by FOS-Treatment in
Pseudomonas aeruginosa PAO1
Due to their relevance to human health, extensive efforts have
been made to study genomic islands, which are large genetic
elements acquired through horizontal transmission (Juhas et al.,
2009; Stephen and Julian, 2015; Mao and Lu, 2016).
Our data, using RNAseq sequence analysis, indicates the
presence of a genomic island in PAO1 of ∼17 kb comprising 15
genes that had been inserted into the 3′-end of the PA0639 gene
(Figure 5) through a phage encoded R2/F2 pyocin (Chang et al.,
2005). Most of its genes were clearly repressed in the presence
of FOS. Unfortunately, most of these genes code for proteins
with unknown functions. Furthermore, in order to determine the
biological role of this genomic island, various isogenic mutants
were constructed and submitted to a phenotypic analysis that
investigates changes in growth, biofilm formation, and motility.
Interestingly, PA0643, PA0644, and PA0646 mutants showed
reduced growth inhibition compared to the wild-type strain
(Figure 6). In addition, while the PA0643 mutant strain did not
cause any significant changes, the PA0644 and PA0646 isogenic
mutant demonstrated a reduction in biofilm formation at 4 and
6 h (Figure 7). Moreover, PA0643, PA0644, and PA0646 mutants
were tested for their ability to swim, swarm, and twitch and the
results showed that the mutants exhibited differences in all three
types of motility (Figure 8). While PA0643, PA0644, and PA0646
mutants caused the same reduced change in swarming motility,
it was found that PA0644 and PA0646 mutants significantly
inhibited (at least 50–60% of WT) the swimming motility.
Interestingly, the twitching motility has been drastically reduced
in the case of the PA0646 mutant (Figure 8). Markedly, this is
the first study which shows that the deletion of PA0643, PA0644,
and PA0646 genes are able to block P. aeruginosa swarming,
swimming, and twitching motility. However, further studies are
required to elucidate the function of these proteins.
DISCUSSION
Various factors appear to be implicated in the ability of
P. aeruginosa to cause health problems. While surface structures,
including pili and the polysaccharide, seem to favor biofilm
formation and adhesion of P. aeruginosa to host cells (Pollack,
1984/1992; Prince, 1992) promoting colonization, its exotoxins in
combination with various secretion systems deteriorate the host’s
defenses. The identification of signal molecules and the study of
their corresponding molecular mechanism, which is associated
with these processes, are of utmost interest.
Prebiotics have been shown to exert beneficial effects
on human health by altering the intestinal microbiota
and also by inhibiting the progression of some pathogenic
strains (Knol et al., 2005), due to an indirect effect caused
by the selective growth of host friendly bacteria. To our
knowledge, antimicrobial properties have been described for
a number of oligosaccharides (Daddaoua et al., 2006) and
in a previous study, it was shown that FOS as a prebiotic
had specific effects on P. aeruginosa, since it reduced growth,
FIGURE 8 | Effect of PA0643, PA0644, and PA0646 deletion on the motility of P. aeruginosa PAO1. Motility assays were carried out as described in section
“Materials and Methods.” Shown are means and standard deviations with n = 3–6; *P < 0.05 vs. WT.
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limited the formation of biofilm, impaired motility, and
reduced the inflammatory response (Ortega-González et al.,
2014). Although, inulin and FOS are structurally related
oligosaccharides, they differ in chain length and both
compounds can be used as a carbon and energy source for P.
aeruginosa growth.
The present study demonstrates that FOS induces a number
of important changes in P. aeruginosa transcript levels some
of which are related to bacterial survival (Figure 1) and
provides an initial insight into the corresponding molecular
mechanisms. As shown in Figure 2, in the 162 genes with
reduced transcript levels by FOS and inulin, only 13% of them
were affected by both compounds. Similarly, of the 443 genes
with increased levels only 24% of gene transcript levels were
altered by both compounds. Therefore, these compounds can
be considered as signal molecules; however, their molecular
mechanisms remain unknown.
RNA-Seq and rt-qPCR based comparative RNA profiling of
P. aeruginosa PAO1 in the presence of FOS or inulin, not only
highlighted known functions required for survival metabolism,
but revealed a decrease in transcript levels of genes associated
with carbohydrate metabolism and growth such as PA1183 (dctA)
which has been shown to be associated previously with bacterial
growth (Valentini et al., 2011). Thus, the growth reduction may
be due to a reduction in transcript levels of genes associated
with carboxylic acid transport, carboxylic acid metabolism, and
reduction in ribosomal proteins.
Furthermore, these studies revealed a decrease of spuI gene
transcript levels (PA0296), confirmed by rt-qPCR (Table 8),
which control the expression of polyamine toxicity and of pyocins
(PA3866), which are virulence factors that are induced by DNA-
damaging agents, such as UV light and mitomycin C (Dean-
Scholl and Martin, 2008).
The current analysis clearly shows that the pathogenesis of
P. aeruginosa in the presence of FOS is compromised due
to a decrease in several virulence-associated genes; i.e., alpB
(PA0908), a holin-like protein that is required for lysis and
the icmP gene (PA4370), which has been shown to degrade
plasminogen activator (Christian et al., 2015) and may play a role
in P. aeruginosa pathogenicity (Tables 5, 8).
Secretion of exotoxins through type III secretion systems
(T3SSs) (Filloux, 2011) are related to acute infections in
P. aeruginosa, while type VI secretion systems are often
associated with chronic infections and biofilm formation
(Silverman et al., 2012).
Here we show by rt-qPCR that FOS lowers the transcript
levels of exsA encoding a transcriptional activator of the secretion
system type (T3SS) as well as those of a key protein necessary for
the secretion system type VI (T6SS) function, encoded by the hcp
gene (Figure 4).
Interestingly, the RNA seq analysis data coincide with a
report that demonstrated that the repression of the ptrB gene
(PA0612) is implicated in the regulation of the T3SS under
DNA damage stress conditions (Weihui and Shouguang, 2005).
In addition, this report demonstrates that a repression of clpV
(PA0090) regulates the biofilm formation and T6SS (Table 5).
Altogether, our study is consistent with the notion that the FOS
mediated reduction in pathogenicity is mediated by the secretion
systems III and VI.
Further, we obtained initial data suggesting that FOS
modulates bacterial resistance to antibiotics, since FOS reduced
the expression of ampD (PA0807) transcription levels which
leads to the constitutive hyperproduction of the beta-lactamase
AmpC and consequently to an increase of the β-lactam
resistance (Lindberg et al., 1987). Furthermore, the data shows
that FOS lowers transcript levels of alpB (PA0908) a gene
product which is related to cell responses to antibiotics
(Alvarez-Ortega et al., 2010).
The RNA seq analysis demonstrated the presence of an island
with different genes of unknown function, whose expression
was completely inhibited in the presence of FOS (Figure 5 and
Table 4). The deletion of the PA0643, PA0644, and PA0646
genes caused alterations in bacterial growth (Figure 6), biofilm
formation (Figure 7) and motility (Figure 8). The alteration
of the transcript levels of this island is thus another possible
mechanism by which FOS reduces bacterial pathogenesis.
CONCLUSION
FOS containing supplements are currently being used to prevent
gastrointestinal infections (Yasuda et al., 2012), suggesting that it
is a valid strategy to combat Pseudomonas infection by potentially
including FOS in antimicrobial cocktails. The present study is
a contribution to close the gap of knowledge that exists in the
corresponding molecular mechanisms.
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